RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Axelyf

Axelyf

Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.

Latest funding

$2.6M Seed ·

Source: startupintros.com

Latest round on record: Seed, October 2026, amount undisclosed.

All 2 rounds ↓
Website: axelyf.com.
LinkedIn: linkedin.com.
Sectors: Biotechnology, Life Science, Medical.
Stage: Seed.
Based in: Brookline, United States.
Last round: Oct 13, 2026 · 10 days ago.
Domain age: 5 years.
On Recent Funding since: Oct 15, 2026.
About Axelyf

Axelyf is a company based in Brookline, United States. Recent Funding lists it under Health and bio (also Logistics and mobility). It raised $2.6M in a Seed round in August 2025, according to startupintros.com. Its latest round on record is a Seed round in October 2026, amount undisclosed. Investors on record include Brunnur Ventures, Omega ehf and Silfurberg. It was founded by John Lucas and Örn Almarsson.

Funding rounds

  1. Seed · amount undisclosed
    Source: sec.gov
  2. Seed · $2.6M
  3. Website created

Founders and team

Investors

Similar Health and bio companies

Questions and sources

Axelyf: questions and answers

How much has Axelyf raised?
Axelyf has raised $2.6M in one sourced round on record (Seed), announced August 29, 2025.
Who invested in Axelyf?
Investors on record for Axelyf: Brunnur Ventures, Omega ehf and Silfurberg.
Who founded Axelyf?
Axelyf was founded by John Lucas and Örn Almarsson.
Where is Axelyf based?
Axelyf is based in Brookline, United States.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/axelyf (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy